Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase

HA Lee, HW Lee, IH Kim, SY Park… - Alimentary …, 2020 - Wiley Online Library
Background Anti‐viral therapy is not indicated for patients with chronic hepatitis B (CHB) in
the immune‐tolerant phase. Aims To investigate the cumulative incidence of phase change …

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

MY Jeon, BK Kim, JS Lee, HW Lee… - Clinical and …, 2020 - pmc.ncbi.nlm.nih.gov
Background/Aims The immune-tolerant (IT) phase of chronic hepatitis B (CHB) patients is
not generally indicative of antiviral therapy (AVT). We assessed and compared the risk of …

Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma

HY Chon, HA Lee, SJ Suh, JI Lee… - Alimentary …, 2021 - Wiley Online Library
Summary Background The modified PAGE‐B (mPAGE‐B) and PAGE‐B models reliably
predict the risk of developing chronic hepatitis B (CHB)‐related hepatocellular carcinoma …

Prevalence and risk factors of cardiovascular disease in patients with chronic hepatitis B

HS Chun, JS Lee, HW Lee, BK Kim, JY Park… - Digestive diseases and …, 2022 - Springer
Background The association between chronic hepatitis B (CHB) and cardiovascular disease
(CVD) remains unclear. We investigated the prevalence and risk factors of CVD in patients …

Perbandingan Indeks Aspartate Aminotransferase to Platelet Ratio Index (Apri) Pada Pasien Sirosis Hepatis dan Karsinoma Hepatoseluler

MRF Nurkamal, V Indriani, IM Harini - Mandala Of Health, 2021 - jos.unsoed.ac.id
Sirosis hepatis dianggap sebagai kondisi sebelum terjadinya karsinoma hepatoseluler.
Sirosis hepatis dan karsinoma hepatoseluler perlu dideteksi lebih awal dengan …